Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Contents

Current Drug Targets, Volume 21 - Number 10



Review Article

The Potential of PI3K/AKT/mTOR Signaling as a Druggable Target for Endometrial and Ovarian Carcinomas

, 21(10): 946 - 961

Csongor György Lengyel*, Sara Cecilia Altuna, Baker Shalal Habeeb, Dario Trapani and Shah Zeb Khan


DOI: 10.2174/1389450120666191120123612



Review Article

BRCA Mutational Status is a Promising Predictive Biomarker for Platinum- based Chemotherapy in Triple-Negative Breast Cancer

, 21(10): 962 - 973

Amal Tazzite*, Hassan Jouhadi, Abdellatif Benider and Sellama Nadifi


DOI: 10.2174/1389450121666200203162541



Review Article

Exploring the Clinical Impact of Predictive Biomarkers in Serous Ovarian Carcinomas

, 21(10): 974 - 995

Cécile Le Page*, Jacqueline Chung, Kurosh Rahimi, Martin Köbel, Diane Provencher and Anne-Marie Mes-Masson


DOI: 10.2174/1389450120666191016143836



Review Article

Trabectedin (Yondelis®) as a Therapeutic Option in Gynecological Cancers: A Focus on its Mechanisms of Action, Clinical Activity and Genomic Predictors of Drug Response

, 21(10): 996 - 1007

Soumaya Souid*, Dorra Aissaoui, Najet Srairi-Abid and Khadija Essafi-Benkhadir


DOI: 10.2174/1389450121666200128161733



Review Article

Prediction of Late Recurrence and Distant Metastasis in Early-stage Breast Cancer: Overview of Current and Emerging Biomarkers

, 21(10): 1008 - 1025

A. Gouri*, B. Benarba, A. Dekaken, H. Aoures and S. Benharkat


DOI: 10.2174/1389450121666200312105908



Review Article (Mini-Review)

Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer?

, 21(10): 1026 - 1033

Khalid El Bairi*, Said Afqir and Mariam Amrani


DOI: 10.2174/1389450121666200425211732



General Review Article

Fibroblast Growth Factors as Tools in the Management of Neuropathic Pain Disorders

, 21(10): 1034 - 1043

Fatemeh Forouzanfar and Hamid R. Sadeghnia*


DOI: 10.2174/1389450121666200423084205




Editor-in-Chief

Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.

Advertisement

Dec-2021-ban

Related Journals

Related eBooks

eBooks Catalog